Cargando…
Plasma C-Terminal Agrin Fragment as an Early Biomarker for Sarcopenia: Results From the GenoFit Study
Barriers associated with direct muscle quantification have prevented a consistent implementation of therapeutic measures for sarcopenia. Recently, the relevance of circulating C-terminal agrin fragment (CAF) as an accessible screening method alternative for sarcopenia has gained credence. Accordingl...
Autores principales: | Pratt, Jedd, De Vito, Giuseppe, Narici, Marco, Segurado, Ricardo, Pessanha, Ludmilla, Dolan, Jackie, Conroy, Judith, Boreham, Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599080/ https://www.ncbi.nlm.nih.gov/pubmed/33993303 http://dx.doi.org/10.1093/gerona/glab139 |
Ejemplares similares
-
Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: findings from GenoFit
por: Pratt, Jedd, et al.
Publicado: (2022) -
Grip strength performance from 9431 participants of the GenoFit study: normative data and associated factors
por: Pratt, Jedd, et al.
Publicado: (2021) -
Genes encoding agrin (AGRN) and neurotrypsin (PRSS12) are associated with muscle mass, strength and plasma C-terminal agrin fragment concentration
por: Pratt, Jedd, et al.
Publicado: (2023) -
Handgrip strength asymmetry as a new biomarker for sarcopenia and individual sarcopenia signatures
por: Pratt, Jedd, et al.
Publicado: (2023) -
C‐terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review
por: Monti, Elena, et al.
Publicado: (2023)